04:26:59 EDT Fri 14 Jun 2024
Enter Symbol
or Name
USA
CA



Myndtec Inc
Symbol MYTC
Shares Issued 23,637,626
Close 2023-05-30 C$ 0.70
Market Cap C$ 16,546,338
Recent Sedar Documents

Myndtec settles debt with director Popovic

2023-08-17 19:05 ET - News Release

Mr. Craig Leon reports

MYNDTEC INC. ANNOUNCES DEBT SETTLEMENT AGREEMENT WITH A DIRECTOR

Myndtec Inc. has entered into a debt settlement agreement as of Aug. 11, 2023, with Dr. Milos Popovic, a director of Myndtec and formerly an interim chief executive officer, to settle an outstanding debt in the amount of $75,000 (hereinafter the obligation). The debt comprises the outstanding balance owed by the company to the director for compensation due to him for services provided as interim CEO in a calendar period prior to 2022.

Pursuant to the debt settlement agreement, Dr. Popovic has agreed and the corporation has accepted that the $75,000 obligation formerly owed to Dr. Popovic is forgiven and not payable by the corporation. From and after Aug. 11, 2023, no interest, fees or other charges shall be calculated or accrued on the obligation, and, except for current director fees, there shall be no other cost, expense, charge or liability owing by the corporation to Dr. Popovic.

About Myndtec Inc.

Myndtec is a Canadian medical technology company dedicated to the development and commercialization of innovative products that improve function, maximize independence and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries. The company develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injury specifically targeted to markets with large, growing and global patient populations.

The company's flagship product, MyndMove, is a non-invasive functional electrical stimulation-based intervention. MyndMove uses neuroplasticity mechanisms to stimulate development of new neural efferent and afferent pathways, allowing patients to re-establish voluntary movement and improve independence in their activities of daily living. The MyndMove system offers trained therapists the ability to assist individuals affected with paralysis to improve voluntary control of their limbs. The MyndMove therapy system offers a broad spectrum of sophisticated functional electrical stimulation software protocols, which therapists customize to patient needs to enable meaningful controlled movements via proprietary stimulation technology.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.